HI
CLPT icon

Harbour Investments’s ClearPoint Neuro CLPT Stock Holding History

Harbour Investments’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-125
Closed -$2K – 3012
2022
Q3 		$2K Hold
125
– – ﹤0.01% 2411
2022
Q2 		$2K Buy
+125
New +$1.28K ﹤0.01% 2411
2021
Q4 		$1K Hold
125
– – ﹤0.01% 2486
2021
Q3 		$2K Hold
125
– – ﹤0.01% 3277
2021
Q2 		$2K Buy
+125
New +$2.42K ﹤0.01% 3350

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Harbour Investments's CLPT Position: Q4 2022 in Review

Harbour Investments sold out of ClearPoint Neuro (CLPT) in Q4 2022, closing a stake of 125 shares — an estimated $2K sold.

Harbour Investments first reported a position in CLPT in Q2 2021 and held it in 5 quarters. The position peaked at $2K in Q3 2022. 62 funds tracked by Wall St. Rank hold CLPT as of Q4 2022.

  • Harbour Investments reported no remaining ClearPoint Neuro position as of Q4 2022 after selling out during the quarter.
  • Harbour Investments sold 125 ClearPoint Neuro shares in Q4 2022, an estimated $2K.
  • Harbour Investments first reported a position in ClearPoint Neuro in Q2 2021 and held it in 5 quarters.
  • Harbour Investments's ClearPoint Neuro position peaked at $2K in Q3 2022.
  • 62 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2022.

Based on Harbour Investments's 13F filing for Q4 2022, filed 16 Feb 2023.